"pancreatic tumor progression" trang 12 - tải miễn phí từ tailieunhanh
The A818–6 system as an in-vitro model for studying the role of the transportome in pancreatic cancer

The A818–6 system as an in-vitro model for studying the role of the transportome in pancreatic cancer
17    88    0
Fatal myositis and spontaneous haematoma induced by combined immune checkpoint inhibitor treatment in a patient with pancreatic adenocarcinoma

Fatal myositis and spontaneous haematoma induced by combined immune checkpoint inhibitor treatment in a patient with pancreatic adenocarcinoma
5    74    0
Comparison of tumour and serum specific microRNA changes dissecting their role in pancreatic ductal adenocarcinoma: A metaanalysis

Comparison of tumour and serum specific microRNA changes dissecting their role in pancreatic ductal adenocarcinoma: A metaanalysis
21    56    0
TIMP-2 secreted by monocyte-like cells is a potent suppressor of invadopodia formation in pancreatic cancer cells

TIMP-2 secreted by monocyte-like cells is a potent suppressor of invadopodia formation in pancreatic cancer cells
14    58    0
Prognostic significance of stem cell/ epithelial-mesenchymal transition markers in periampullary/pancreatic cancers: FGFR1 is a promising prognostic marker

Prognostic significance of stem cell/ epithelial-mesenchymal transition markers in periampullary/pancreatic cancers: FGFR1 is a promising prognostic marker
14    93    0
Validation and modification of staging systems for poorly differentiated pancreatic neuroendocrine carcinoma

Validation and modification of staging systems for poorly differentiated pancreatic neuroendocrine carcinoma
8    69    0
Early relapse on adjuvant gemcitabine associated with an exceptional response to 2nd line capecitabine chemotherapy in a patient with pancreatic adenosquamous carcinoma with strong intra-tumoural expression of cytidine deaminase: A case report

Early relapse on adjuvant gemcitabine associated with an exceptional response to 2nd line capecitabine chemotherapy in a patient with pancreatic adenosquamous carcinoma with strong intra-tumoural expression of cytidine deaminase: A case report
6    55    0
Correlation of skin rash and overall survival in patients with pancreatic cancer treated with gemcitabine and erlotinib – results from a non-interventional multi-center study

Correlation of skin rash and overall survival in patients with pancreatic cancer treated with gemcitabine and erlotinib – results from a non-interventional multi-center study
8    70    0
Identification of dissociation factors in pancreatic Cancer using a mass spectrometry-based proteomic approach

Identification of dissociation factors in pancreatic Cancer using a mass spectrometry-based proteomic approach
9    58    0
Non-functional pancreatic neuroendocrine tumours: Emerging trends in incidence and mortality

Non-functional pancreatic neuroendocrine tumours: Emerging trends in incidence and mortality
10    111    0
Successful resection of pancreatic metastasis from oesophageal squamous cell carcinoma: A case report and review of the literature

Successful resection of pancreatic metastasis from oesophageal squamous cell carcinoma: A case report and review of the literature
5    65    0
PDAC-ANN: An artificial neural network to predict pancreatic ductal adenocarcinoma based on gene expression

PDAC-ANN: An artificial neural network to predict pancreatic ductal adenocarcinoma based on gene expression
11    68    0
The impact of neoadjuvant and adjuvant immunotherapy on the survival of pancreatic cancer patients: A retrospective analysis

The impact of neoadjuvant and adjuvant immunotherapy on the survival of pancreatic cancer patients: A retrospective analysis
10    66    0
MicroRNAs in Pancreatic Cancer: Biomarkers, prognostic, and therapeutic modulators

MicroRNAs in Pancreatic Cancer: Biomarkers, prognostic, and therapeutic modulators
13    89    0
Overall survival in patients over 40 years old with surgically resected pancreatic carcinoma: A SEER-based nomogram analysis

Overall survival in patients over 40 years old with surgically resected pancreatic carcinoma: A SEER-based nomogram analysis
9    94    0
Comparative effectiveness of primary tumor resection in patients with stage III pancreatic adenocarcinoma

Comparative effectiveness of primary tumor resection in patients with stage III pancreatic adenocarcinoma
8    68    0
Irreversible electroporation versus radiotherapy after induction chemotherapy on survival in patients with locally advanced pancreatic cancer: A propensity score analysis

Irreversible electroporation versus radiotherapy after induction chemotherapy on survival in patients with locally advanced pancreatic cancer: A propensity score analysis
11    54    0
High methylation levels of PCDH10 predict poor prognosis in patients with pancreatic ductal adenocarcinoma

High methylation levels of PCDH10 predict poor prognosis in patients with pancreatic ductal adenocarcinoma
11    55    0
Body weight loss after surgery affects the continuity of adjuvant chemotherapy for pancreatic cancer

Body weight loss after surgery affects the continuity of adjuvant chemotherapy for pancreatic cancer
10    110    0
A multicenter phase 4 geriatric assessment directed trial to evaluate gemcitabine +/− nab-paclitaxel in elderly pancreatic cancer patients (GrantPax)

A multicenter phase 4 geriatric assessment directed trial to evaluate gemcitabine +/− nab-paclitaxel in elderly pancreatic cancer patients (GrantPax)
7    90    0